Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 2/20 | 0.64 |
| ▸ | HTR2C | P28335 | 1/20 | 0.64 |
| ▸ | HTR2B | P41595 | 1/20 | 0.64 |
| ▸ | GRB2 | P62993 | 1/20 | 0.59 |
| ▸ | SLC7A5 | Q01650 | 7/20 | 0.59 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.59 |
| ▸ | ALPI | P09923 | 1/20 | 0.59 |
| ▸ | PKM | P14618 | 1/20 | 0.59 |
| ▸ | XIAP | P98170 | 1/20 | 0.59 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.56 |
| ▸ | NOS3 | P29474 | 2/20 | 0.55 |
| ▸ | NOS1 | P29475 | 2/20 | 0.55 |
| ▸ | NOS2 | P35228 | 2/20 | 0.55 |
| ▸ | PPARG | P37231 | 1/20 | 0.55 |
| ▸ | PPARA | Q07869 | 1/20 | 0.55 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.54 |
| ▸ | DPP4 | P27487 | 1/20 | 0.53 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.53 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.53 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29557134 | 1.00 | HTR2A (0.64) | HTR2AHTR2CHTR2BGRB2SLC7A5 | |
| SCHEMBL503602 | 1.00 | HTR2A (0.64) | HTR2AHTR2CHTR2BGRB2SLC7A5 | |
| SCHEMBL44156 | 1.00 | HTR2A (0.64) | HTR2AHTR2CHTR2BGRB2SLC7A5 | |
| SCHEMBL29478401 | 1.00 | HTR2A (0.64) | HTR2AHTR2CHTR2BGRB2SLC7A5 | |
| Hydrochloric Acid SCHEMBL10584250 | 0.98 | HTR2A (0.62) | HTR2AHTR2CHTR2BGRB2SLC7A5 | |
| Hydrochloric Acid SCHEMBL6775624 | 0.98 | HTR2A (0.62) | HTR2AHTR2CHTR2BGRB2SLC7A5 | |
| Hydrochloric Acid SCHEMBL6775619 | 0.98 | HTR2A (0.62) | HTR2AHTR2CHTR2BGRB2SLC7A5 | |
| SCHEMBL6831079 | 0.88 | PPARG (0.60) | HTR2AHTR2CHTR2BGRB2SLC7A5 | |
| SCHEMBL16131653 | 0.88 | HTR2A (0.69) | HTR2AHTR2CHTR2BEPHX1DPP4 | |
| SCHEMBL19943590 | 0.88 | HTR2A (0.69) | HTR2AHTR2CHTR2BEPHX1DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1313 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120081924-A | GLP-1R receptor agonistic polypeptide compounds and uses thereof | 中国药科大学 | 2025-06-03 | — | — | CN | claimed |
| CN-119390784-A | Dual-agonism polypeptide compound and medical application thereof | 中国药科大学 | 2025-02-07 | — | — | CN | claimed |
| CN-118440155-B | Dual-agonism polypeptide compound and medical application thereof | 中国药科大学 | 2024-11-22 | — | — | CN | claimed |
| US-20240376044-A1 | METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2024-11-14 | — | — | US | claimed |
| CN-118546214-A | GLP-1R receptor agonistic polypeptide compounds and uses thereof | 中国药科大学 | 2024-08-27 | — | — | CN | claimed |
| CN-118440155-A | Dual-agonism polypeptide compound and medical application thereof | 中国药科大学 | 2024-08-06 | — | — | CN | claimed |
| CN-105143245-B | Anti-scaling material | 耶路撒冷希伯来大学伊森姆研究发展有限公司 | 2021-02-05 | — | — | CN | claimed |
| EP-2951195-B1 | ANTIFOULING MATERIALS | YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD (IL) | 2020-02-19 | — | — | EP | claimed |
| US-9631100-B2 | Antifouling materials | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2017-04-25 | — | — | US | claimed |
| US-20150368480-A1 | ANTIFOULING MATERIALS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD (IL) | 2015-12-24 | — | — | US | claimed |
| WO-2008031016-A2 | HETEROCYCLIC LIGANDS FOR INTEGRIN IMAGING AND THERAPY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2008-03-13 | — | — | WO | claimed |
| US-7053214-B2 | β-sheet mimetics and composition and methods relating thereto | MYRIAD GENETICS, INC. (US) | 2006-05-30 | — | — | US | claimed |
| WO-2005122379-A9 | ALPHA-4 BETA-1 INTEGRIN LIGANDS FOR IMAGING AND THERAPY | UNIV CALIFORNIA (US) | 2006-03-09 | — | — | WO | claimed |
| US-20060019900-A1 | Alpha-4 beta-1 integrin ligands for imaging and therapy | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2006-01-26 | — | — | US | claimed |
| WO-2005122379-A2 | ALPHA-4 BETA-1 INTEGRIN LIGANDS FOR IMAGING AND THERAPY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2005-12-22 | — | — | WO | claimed |
| US-6943157-B2 | Reverse-turn mimetics and composition and methods relating thereto | MYRIAD GENETICS, INC. (US) | 2005-09-13 | — | — | US | claimed |
| US-20020039749-A1 | High-throughput screening assays for modulators of STAT4 and STAT6 activity | AMGEN INC. | 2002-04-04 | — | — | US | claimed |
| US-6207391-B1 | INCUBATING A REACTION MIXTURE COMPRISING A STAT6 POLYPEPTIDE, A POTENTIAL BINDING MODULATOR, AND A RECEPTOR PEPTIDE WHICH COMPRISES A SPECIFIC AMINO ACID SEQUENCE | TULARIK INC. | 2001-03-27 | — | — | US | claimed |
| WO-1999050283-A1 | HIGH THROUGHPUT SCREENING ASSAYS FOR MODULATORS OF STAT4 AND STAT6 ACTIVITY | TULARIK INC. (US) | 1999-10-07 | — | — | WO | claimed |
| US-5658885-A | OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-08-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060019900-A1 | Alpha-4 beta-1 integrin ligands for imaging and therapy | ITGA4, ITGB4, ITGA1 | HTR2A 3306/4885HTR2C 3517/4885HTR2B 1980/4885 |
| US-20240376044-A1 | METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE | DDC, AADAT, TYR | HTR2A 2278/4885HTR2C 2836/4885HTR2B 2599/4885 |
| US-20150368480-A1 | ANTIFOULING MATERIALS | PFAS, FLNB, FLNA | HTR2A 3133/4885HTR2C 3439/4885HTR2B 2881/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.